Synthace and Ipsen partner to accelerate novel therapeutic development through automation
Two European leaders in biopharma and integrative software are working together to advance drug discovery
Two European leaders in biopharma and integrative software are working together to advance drug discovery
The technology is said to be superior at identifying cell types in human blood, providing faster and more reliable assessments for clinical decision making
Partnership to evaluate the use of Affimer reagents to detect the coronavirus using novel sensors
The cutting-edge technology is utilized to aid drug development and medical equipment production
The use of protein biomarkers in oncology is growing rapidly and offers real hope to patients with hard-to-treat cancers
Carriers of two copies of the APOE ε4 allele have an increased risk of adverse reaction
The new instrument aims to offer a highly versatile recapping system to enhance user experiences
New offering focuses on ICPMS instruments
07:00 PDT / 10:00 EDT / 15:00 BST / 16:00 CEST, July 15th 2015